{
    "code": "01015387",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01015387",
    "time": "2020-02-25 02:31:42",
    "許可證字號": "衛署藥製字第015387號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/08\/14",
    "發證日期": "67\/08\/14",
    "許可證種類": "製　劑",
    "舊證字號": "00000000",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00101538705",
    "中文品名": "能百鎮錠２５０公絲（那普洛仙）",
    "英文品名": "NAPOSIN TABLETS (NAPROXEN)250MG",
    "適應症": "急慢性風濕關節炎、關節局部腫脹、強直性脊椎關節炎、脊椎炎、椎關節炎、關節周圍炎、上腕肩甲骨炎及骨骼肌不適之粘液囊炎、腱鞘炎之消炎、鎮痛解熱",
    "劑型": "110錠劑",
    "包裝": "盒裝 塑膠容器裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "0402606200  中國化學製藥股份有限公司新豐工廠",
        "申請商地址": "新竹縣新豐鄉坑子口１８２之１號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808402000",
            "成分名稱": "NAPROXEN",
            "含量描述": "250",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "淡黃橙",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓扁形",
        "標記一": "CCP,D31",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "衛署藥製字第015387號_500PTP_藥物外觀-108-06-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01015387&Seq=073&Type=10"
        },
        {
            "title": "01015387.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01015387&Seq=071&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Naposin Tabs. 250mg In-106-04-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01015387&Seq=004&Type=9"
        },
        {
            "title": "A015387 In-104-11-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01015387&Seq=003&Type=9"
        },
        {
            "title": "衛署藥製字第015387號_500PTPL_鋁箔外觀外盒1-108-06-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01015387&Seq=007&Type=8"
        },
        {
            "title": "衛署藥製字第015387號_500PTPL_鋁箔外觀外盒-108-06-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01015387&Seq=005&Type=8"
        },
        {
            "title": "015387外盒標籤鋁箔-106-04-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01015387&Seq=003&Type=8"
        },
        {
            "title": "Naposin Tabs. 250mg Al-foil-106-04-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01015387&Seq=002&Type=8"
        },
        {
            "title": "Naposin Tablets 250 mg La-106-04-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01015387&Seq=001&Type=8"
        }
    ]
}